CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale SVP, Chief Operating Officer sold 8,661 shares at $1.58 ($13,684)
- 4 Open-market sale SVP, Chief Legal Officer sold 5,974 shares at $1.58 ($9,439)
- 4 Open-market sale CEO and President sold 46,570 shares at $1.58 ($73,581)
- 4 Open-market sale SVP, Chief Medical Officer sold 7,169 shares at $1.58 ($11,327)
- 4 Planned sale SVP, Chief Legal Officer sold 7,411 shares at $1.52 ($11,265)
- 4 Open-market sale SVP, Chief Operating Officer sold 10,744 shares at $1.52 ($16,331)
- 4 Planned sale SVP, Chief Medical Officer sold 8,367 shares at $1.52 ($12,718)
- 4 Open-market sale CEO and President sold 37,733 shares at $1.52 ($57,354)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
Page 8 of 45 · 886 filings